The Australian Antibiotic Trial in Crohn's Disease: Alternative Conclusions From the Same Study

Gastroenterology

Volumn 133, Issue 5, 2007, Pages 1742-1743

  Kuenstner, J Todd ^a  

^a West Allis Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; INFLIXIMAB; RIFABUTIN;

BLOOD CULTURE; COMBINATION CHEMOTHERAPY; CROHN DISEASE; ERADICATION THERAPY; HUMAN; LETTER; MYCOBACTERIUM AVIUM; MYCOBACTERIUM PARATUBERCULOSIS; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; CLOFAZIMINE; CROHN DISEASE; DRUG THERAPY, COMBINATION; HUMANS; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; PARATUBERCULOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; RIFABUTIN;

EID: 35648941733     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.09.012     Document Type: Letter

References (4)

1. Naser S., Ghobrial G., Romero C., et al. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 364 (2004) 1039-1044
2. Shafran S., Singer J., Zarowny D., et al. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol clofazimine, and ciprofloxacin. N Engl J Med 335 (1996) 377-383
3. Ellingson J., Anderson J., Koziczkowski J., et al. Detection of viable Mycobacterium avium subsp. paratuberculosis in retail pasteurized whole milk by two culture methods and PCR. J Food Prot 68 (2005) 966-972
4. St-Jean G., and Jernigan A. Treatment of Mycobacterium paratuberculosis infection in ruminants. Vet Clin North Am Food Anim Pract 7 (1991) 793-804